Comprehensive suite of molecular biology and sequence analysis tools

Free TrialPricing

Unlock the value of your sequence data

Sequence Analysis and Genomics

  • User-friendly, intuitive interface packed full of essential genomic tools
  • Sanger, NGS and long read sequence analysis
  • Pairwise and multiple alignments
  • De novo assembly and reference mapping
  • Expression analysis and variant calling
  • Phylogenetic tree building

Molecular Biology

  • Single interface for wide-range of cloning and primer design operations 
  • Automatically annotate plasmid maps and expression vectors
  • Simulate a variety of molecular cloning operations
  • Design and test primers, find CRISPR sites, and optimize codons

Data Management

  • Simple drag and drop for import and export
  • Convert common file formats including GenBank, SnapGene, FASTQ
  • Import your complete Vector NTI database
  • Document filtering, batch renaming, and automatic document history

The backbone of your scientific research

Automate

  • Create your own automated workflows or use in-built workflows to increase efficiency and reduce human error
  • Connect directly to databases including UniProt, NCBI (Entrez), BLAST and PubMed
  • Automate databases searches to continuously receive the latest information on genomes, sequences, and protein structures

Collaborate

  • Increase process efficiency and improve collaboration with intuitive folder-based organization and a seamlessly integrated shared database
  • Geneious Server Database is also available to purchase with a greater level of control and increased security for data access for your organization over the standard shared database

Customize

  • Extend the functionality of Geneious Prime with our collection of plugins available for assembly, alignment, phylogenetics and more
  • Integrate with existing systems and add your own custom algorithms using a highly interoperable API

Free Trial

Geneious is an absolutely beautiful package to work with. We love it and we are telling everyone about it.
Charles MooreNovartis Pharma AG, Switzerland